Raymond James & Associates GENOMIC HEALTH INC Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 12, 2020	SELL	N/A	-15,575 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	N/A	3,603 Added 30.1%	15,575 $1.06 Million
Q2 2019 Aug 06, 2019	SELL	N/A	-4,086 Reduced 25.45%	11,972 $696,000
Q1 2019 May 06, 2019	BUY	N/A	1,782 Added 12.48%	16,058 $1.13 Million
Q4 2018 Feb 11, 2019	SELL	N/A	-844 Reduced 5.58%	14,276 $920,000
Q3 2018 Nov 14, 2018	BUY	N/A	158 Added 1.06%	15,120 $1.06 Million
Q2 2018 Aug 14, 2018	BUY	N/A	624 Added 4.35%	14,962 $754,000
Q1 2018 May 14, 2018	BUY	N/A	461 Added 3.32%	14,338 $449,000
Q4 2017 Feb 14, 2018	BUY	N/A	764 Added 5.83%	13,877 $475,000
Q3 2017 Nov 13, 2017	BUY	N/A	379 Added 2.98%	13,113 $421,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,734	12,734 $414,000

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.